{
    "Trade/Device Name(s)": [
        "BioPlex 2200 HSV-1 & HSV-2 IgG Kit",
        "BioPlex 2200 HSV-1 & HSV-2 IgG Calibrator Set",
        "BioPlex 2200 HSV-1 & HSV-2 IgG Control Set",
        "BioPlex HSV-1 & HSV-2 IgG on the BioPlex 200 Multi-Analyte Detection System"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K120959",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090409"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ",
        "MYF",
        "JIX",
        "JJY"
    ],
    "Summary Letter Date": "March 28, 2012",
    "Summary Letter Received Date": "March 30, 2012",
    "Submission Date": "June 22, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.3305",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Serological Assays",
        "Calibrator",
        "Quality control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "IgG antibodies to herpes simplex virus type 1 (HSV-1)",
        "IgG antibodies to herpes simplex virus type 2 (HSV-2)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA plasma",
        "Heparinized plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioPlex 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay",
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Multiplex immunoassay",
        "Serological testing"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control",
        "Reagent",
        "Instrument",
        "Software System"
    ],
    "Document Summary": "FDA 510(k) summary for BioPlex 2200 HSV-1 & HSV-2 IgG Kit, Calibrator Set, and Control Set for qualitative detection and differentiation of HSV-1 and HSV-2 IgG antibodies using multiplex flow immunoassay",
    "Indications for Use Summary": "Aids in qualitative detection and differentiation of IgG antibodies to HSV-1 and HSV-2 in human serum and EDTA or heparinized plasma for sexually active individuals and expectant mothers as a presumptive diagnostic aid; not cleared for blood/plasma donor screening or for point-of-care, pediatric, neonatal, or immunocompromised populations.",
    "fda_folder": "Microbiology"
}